Jan 04, 2022 4:05pm EST Virios Therapeutics to Present at the Virtual H.C. Wainwright BioConnect Conference
Dec 01, 2021 7:05am EST Virios Therapeutics Achieves Over 50% Enrollment Milestone in its Phase 2b Clinical Trial for Fibromyalgia
Nov 11, 2021 7:05am EST Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Nov 04, 2021 7:05am EDT Virios Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Thursday, November 11, 2021
Sep 02, 2021 7:05am EDT Virios Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 16, 2021 7:05am EDT Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview
Aug 12, 2021 7:05am EDT Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update
